Proof of Usefulness Report

MediVentures

Analysis completed on 2/13/2026

+14
Proof of Usefulness Score
You're In Business

The submission describes 'MediVentures', a legitimate corporate VC arm of the MEDICE Health Family, but the entry quality is extremely low and contains factually impossible claims (e.g., 'most people have used my product'). The stated revenue/market cap ($500k) is inconsistent with a functional VC fund, suggesting either a misunderstanding of the metrics, a tokenized project using the name, or a spam submission. Due to the lack of verifiable evidence, false traction claims, and zero technical detail, the score is minimal.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+25.0
Audience Reach Impact+10.0
Technical Innovation+5.0
Evidence Of Traction+5.0
Market Timing Relevance+20.0
Functional Completeness+5.0
Subtotal+12.5
Usefulness Multiplierx1.12
Final Score+14

Project Details

Project URL
Description
At MediVentures we support innovative technologies and brilliant entrepreneurs within Life Sciences and the Digital Health sector. We primarily invest through investment funds and take select stakes in their portfolio companies. MediVentures is partner of the MEDICE Health Family (www.medice.com). Get in touch with us at info@medi.ventures.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline